Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Postmenopausal Symptoms: later-stage trial registry
2 of 8 indexed Postmenopausal Symptoms trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Postmenopausal Symptoms: 8 US clinical trials tracked, 2 recruiting.
Postmenopausal Symptoms is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is J3 Bioscience, running 1 of these trials.
Enrollment posture brief
Registry condition postmenopausal-symptoms
OPEN 2 | RECR 25% | LATE 2 | EARLY 1 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)
Postmenopausal Symptoms lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Postmenopausal Symptoms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Postmenopausal Symptoms is recruiting below its size-band peers.
2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Postmenopausal Symptoms trials is spread across many organizations.
J3 Bioscience accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Postmenopausal Symptoms trials plan to enrol fewer than 100 people.
Median target enrolment is 72 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.
-
Postmenopausal Symptoms research is mostly interventional.
8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
Julie Pendergast
NCT04893226
Exercise Training and Fat Metabolism in Postmenopausal Women
Florida State University
NCT05351476
PRP Injections for Genitourinary Syndrome of Menopause
Medstar Health Research Institute
NCT06028009
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
ASCEND Therapeutics
NCT00160173
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
J3 Bioscience
NCT03150407
Inspiratory Muscle Training in Postmenopausal Women
Indiana University
NCT06459674
Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy
University of Alabama at Birmingham
NCT03996603
Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women
Noven Therapeutics
NCT01829919
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Postmenopausal Symptoms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Postmenopausal Symptoms trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Postmenopausal Symptoms page
8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Postmenopausal Symptoms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- J3 Bioscience sponsors the most Postmenopausal Symptoms trials on record, review their full trial history before evaluating a specific study. See J3 Bioscience's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postmenopausal Symptoms condition card totals 8 registered trials; most-linked intervention VR101 Device (Safety); top US site state Alabama. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.